
Tom Anchordoquy
-
Professor of Pharmaceutical Sciences,
University of Colorado Anschutz Medical Campus
I joined the faculty at the CU School of Pharmacy in 1998, and my early work focused on the stability of lipid-DNA complexes during freezing and drying. In attempting to assess“recovery” of these new pharmaceutical entities, I became interested in the mechanism by which they facilitated delivery to target cells. In over a decade of work, we eventually realized that these particles were being avidly taken up by circulating immune cells that elicited a potent cytokine response upon intravenous injection. In addition to our work attempting to exploit exosomes for drug delivery, our current projects investigate strategies that harness the nanoparticle-induced immune response to limit off-target accumulation of nanomedicines and promote tumor regression. In addition to these projects, my lab is constantly involved in multiple formulation studies that utilize small molecules to treat a variety of diseases.
Experience-
–present
Professor of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Salvium Solves The Privacy Paradox: Salvium One Delivers Mica-Compliant Privacy That Exchanges Can List
- Cregis At TOKEN2049 Singapore 2025: Unlocking The Next Frontier Of Adoption
- Moonbirds And Azuki IP Coming To Verse8 As AI-Native Game Platform Integrates With Story
- CEA Industries ($BNC) Announces BNB Holdings Of 480,000 Tokens, And Total Crypto And Cash Holdings Of $663 Million
- SPAYZ.Io White Paper Explores Opportunities, Challenges And Ambitions In Payments Industry
- Solstice Announces Strategic Collaboration With Chainlink And Leading Custody And Venture Firms To Enhance Ecosystem Ahead Of USX Stablecoin Launch
Comments
No comment